Patients & CaregiversHealthcare Professionals - Opens new windowWorldwide - Opens new window
Quick Find - Click to open on a page
HomeAbout MerckProductsNewsroomInvestor RelationsCareersResearchLicensingThe Merck Manuals
Contact us Contact Newsroom
Podcasts Podcast
RSS RSS

Newsroom
Welcome to the Merck Newsroom
This site is designed to provide members of the media with quick and easy access to recent information about Merck. Here you will find product, research and development, corporate, and financial news releases, webcasts and executive speeches and information relating to the voluntary withdrawal of VIOXX (rofecoxib). For additional information, please visit About Merck.
Product News Corporate News
Research & Development News Financial News
Corporate Responsibility News  

Product News

 More product news
12 Jun 2009 Merck Statement in Response to the FDA's June 12, 2009 Communication with Updated Information on Leukotriene Inhibitors, Including SINGULAIR® (montelukast sodium)
Acrobat PDF file Full Prescribing Information Acrobat PDF file Patient Product Information
08 Jun 2009 Initial Therapy with JANUMET™ (sitagliptin/metformin) Provided Significantly Greater Blood Sugar Lowering Compared to Metformin Alone in Patients with Type 2 Diabetes
Acrobat PDF file Full Prescribing Information Acrobat PDF file Full Prescribing Information
Acrobat PDF file Patient Product Information Acrobat PDF file Patient Product Information
06 Jun 2009 In Investigational Studies, New Uses of JANUVIA™ (sitagliptin) in Combination with Other Diabetes Medicines Resulted In Significant Blood Sugar-Lowering Efficacy for Patients with Type 2 Diabetes
Acrobat PDF file Full Prescribing Information Acrobat PDF file Full Prescribing Information
Acrobat PDF file Patient Product Information Acrobat PDF file Patient Product Information

RESEARCH & DEVELOPMENT News

 More research and development news
22 Jun 2009 Merck & Co., Inc. and Drugs for Neglected Diseases initiative Collaborate to Find Treatments for World's Most Neglected Tropical Diseases
05 Jun 2009 Rolofylline Did Not Demonstrate Efficacy for Acute Heart Failure in Clinical Trial
01 Jun 2009 AstraZeneca and Merck & Co., Inc. Form Pioneering Collaboration to Investigate Novel Combination Anticancer Regimen

Corporate News

 More corporate news
22 Jun 2009 Merck and Schering-Plough Receive Request for Additional Information from FTC Regarding Proposed Merger
20 Jun 2009 Merck & Co., Inc. Statement on Medicare Part D Assistance
29 May 2009 Merck Statement on United States Patent & Trademark Office Decision to Reexamine the SINGULAIR® Patent

Financial News

 More financial news
22 Jun 2009 Merck Prices $4.25 Billion Debt Offering
02 Jun 2009 Merck to Hold Second-Quarter 2009 Sales and Earnings Conference Call on July 21
27 May 2009 Merck Announces Third-Quarter 2009 Dividend

CORPORATE RESPONSIBILITY News

 More corporate responsibility news
29 Jun 2009 Nation's Top 37 Minority Students Awarded Prestigious UNCF/MERCK Science Scholarships & Fellowships
22 Jun 2009 The Earth Institute and Merck & Co., Inc./The Merck Company Foundation partner to strengthen health services in rural Africa
09 Jun 2009 Corporations Need to Tackle Global Corruption as Strategic CSR Effort

top

*Software to view files presented in PDF or SWF format is available at no charge through the Adobe Web site. Get Adobe Reader Get Adobe Flash Player

Printer Friendly Page
 
Contact Merck Site Map Accessibility Statement Privacy Policy Terms of Use Copyright 1995-2008 Merck & Co., Inc.